Drug Shortage Report for METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION

Last updated on 2020-02-13 History
Report ID 1714
Drug Identification Number 02241229
Brand name METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION
Common or Proper name METHYLPREDNISOLONE SODIUM SUCCINATE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) METHYLPREDNISOLONE
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2016-02-29
Estimated end date 2022-12-01
Actual end date
Shortage status Actual shortage
Updated date 2020-02-13
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-13 French Compare
v3 2020-02-13 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare